Live Quote · NASDAQKARDHealthcare· Biotechnology

Kardigan, Inc.

$21.13▲ 0.52%(+$0.11)
TickerSpark Score

Limited financial coverage for KARD.

Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.

30
Momentum
52-Week Range45% of range
Low
$16.25
Current
$21.13
High
$27.00
Company Overviewwww.kardigan.bio

About the company

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes.

CEO
Tassos Gianakakos
IPO
2026
Employees
241
HQ
Princeton, NJ, US

Price Chart

-3.95% · this period
$25.90$23.46$21.02Jun 18Jul 06Jul 17

Get TickerSpark's AI analysis on KARD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in